BORTOT, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 464
AS - Asia 113
EU - Europa 103
SA - Sud America 10
AF - Africa 1
Totale 691
Nazione #
US - Stati Uniti d'America 461
SG - Singapore 42
CN - Cina 23
RU - Federazione Russa 23
HK - Hong Kong 21
DE - Germania 19
IT - Italia 19
VN - Vietnam 17
BR - Brasile 9
BE - Belgio 7
UA - Ucraina 7
IE - Irlanda 6
IN - India 6
FI - Finlandia 5
FR - Francia 5
AT - Austria 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
LT - Lituania 2
CA - Canada 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
LV - Lettonia 1
NI - Nicaragua 1
NL - Olanda 1
PL - Polonia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 691
Città #
Chandler 61
Fairfield 48
Ashburn 46
Ann Arbor 33
Singapore 32
Seattle 28
Hong Kong 21
Woodbridge 20
Houston 19
Wilmington 18
Cambridge 17
Dong Ket 17
New York 14
Boardman 12
Beijing 8
Dearborn 8
Princeton 8
Brussels 7
Dublin 6
Redmond 6
Jacksonville 5
Martignacco 5
Frankfurt am Main 4
Nanjing 4
San Diego 4
Helsinki 3
Jinan 3
Munich 3
Nuremberg 3
Scafati 3
Washington 3
Brno 2
Leawood 2
Los Angeles 2
Ogden 2
Phoenix 2
Udine 2
Arima 1
Asti 1
Atlanta 1
Augusta 1
Bento Gonçalves 1
Cairo 1
Camaçari 1
Campina Grande 1
Chongqing 1
Dallas 1
Des Moines 1
Divinópolis 1
Dushanbe 1
Hyderabad 1
Kunming 1
Lagoa dos Gatos 1
Langfang 1
Lappeenranta 1
Lauterbourg 1
London 1
Lucknow 1
Managua 1
Melfi 1
Milan 1
Nanchang 1
Newark 1
Norfolk 1
Nova Friburgo 1
Olive Branch 1
Panambi 1
Parauapebas 1
Quito 1
Riga 1
San Remo 1
Santa Clara 1
Tel Aviv 1
Tokyo 1
Toronto 1
Trento 1
Turku 1
Wenzhou 1
Wuhan 1
Xaxim 1
Totale 524
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 141
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 117
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 111
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 99
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer 83
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 71
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 50
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva 46
Totale 718
Categoria #
all - tutte 3.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.221


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 0 7
2020/2021179 8 11 25 33 9 18 8 13 6 10 14 24
2021/202279 11 9 0 1 1 0 6 2 0 10 31 8
2022/2023114 10 16 0 19 14 21 0 7 19 2 4 2
2023/202469 3 5 3 2 15 23 0 2 4 2 0 10
2024/2025169 2 9 7 10 13 8 17 9 24 13 22 35
Totale 718